Phase Ib Trial of Encapsulated Rapamycin (eRapa) in Prostate Cancer Patients Under Active Surveillance
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2019
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 09 Nov 2019 Planned End Date changed from 15 Jan 2020 to 15 Jul 2020.
- 09 Nov 2019 Planned primary completion date changed from 15 Aug 2019 to 15 Jan 2020.
- 09 Nov 2019 Status changed from recruiting to active, no longer recruiting.